An Open Study of Foscarnet Treatment First Episode CMV-Retinitis in AIDS Patients
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of foscarnet induction therapy for treatment of AIDS
patients experiencing their first episode of cytomegalovirus (CMV) retinitis. To evaluate the
safety and efficacy of three different foscarnet maintenance therapy regimens. To determine
the pharmacokinetics of intermittent administration of foscarnet with or without concomitant
administration of zidovudine (AZT).